Stain SAN: simultaneous augmentation and normalization for histopathology images.

batch adjustment color transformation domain adaptation histopathology tissue staining

Journal

Journal of medical imaging (Bellingham, Wash.)
ISSN: 2329-4302
Titre abrégé: J Med Imaging (Bellingham)
Pays: United States
ID NLM: 101643461

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 09 12 2023
revised: 06 07 2024
accepted: 25 07 2024
pmc-release: 23 08 2025
medline: 26 8 2024
pubmed: 26 8 2024
entrez: 26 8 2024
Statut: ppublish

Résumé

We address the need for effective stain domain adaptation methods in histopathology to enhance the performance of downstream computational tasks, particularly classification. Existing methods exhibit varying strengths and weaknesses, prompting the exploration of a different approach. The focus is on improving stain color consistency, expanding the stain domain scope, and minimizing the domain gap between image batches. We introduce a new domain adaptation method, Stain simultaneous augmentation and normalization (SAN), designed to adjust the distribution of stain colors to align with a target distribution. Stain SAN combines the merits of established methods, such as stain normalization, stain augmentation, and stain mix-up, while mitigating their inherent limitations. Stain SAN adapts stain domains by resampling stain color matrices from a well-structured target distribution. Experimental evaluations of cross-dataset clinical estrogen receptor status classification demonstrate the efficacy of Stain SAN and its superior performance compared with existing stain adaptation methods. In one case, the area under the curve (AUC) increased by 11.4%. Overall, our results clearly show the improvements made over the history of the development of these methods culminating with substantial enhancement provided by Stain SAN. Furthermore, we show that Stain SAN achieves results comparable with the state-of-the-art generative adversarial network-based approach without requiring separate training for stain adaptation or access to the target domain during training. Stain SAN's performance is on par with HistAuGAN, proving its effectiveness and computational efficiency. Stain SAN emerges as a promising solution, addressing the potential shortcomings of contemporary stain adaptation methods. Its effectiveness is underscored by notable improvements in the context of clinical estrogen receptor status classification, where it achieves the best AUC performance. The findings endorse Stain SAN as a robust approach for stain domain adaptation in histopathology images, with implications for advancing computational tasks in the field.

Identifiants

pubmed: 39185474
doi: 10.1117/1.JMI.11.4.044006
pii: 23360GRR
pmc: PMC11342968
doi:

Types de publication

Journal Article

Langues

eng

Pagination

044006

Informations de copyright

© 2024 The Authors.

Auteurs

Taebin Kim (T)

University of North Carolina at Chapel Hill, Department of Statistics and Operations Research, Chapel Hill, North Carolina, United States.

Yao Li (Y)

University of North Carolina at Chapel Hill, Department of Statistics and Operations Research, Chapel Hill, North Carolina, United States.

Benjamin C Calhoun (BC)

University of North Carolina at Chapel Hill, Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina, United States.
University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States.

Aatish Thennavan (A)

The University of Texas MD Anderson Cancer Center, Department of Systems Biology, Houston, Texas, United States.

Lisa A Carey (LA)

University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States.
University of North Carolina at Chapel Hill, Department of Medicine, Chapel Hill, North Carolina, United States.

W Fraser Symmans (WF)

The University of Texas MD Anderson Cancer Center, Department of Pathology, Houston, Texas, United States.
The University of Texas MD Anderson Cancer Center, Department of Translational Molecular Pathology, Houston, Texas, United States.

Melissa A Troester (MA)

University of North Carolina at Chapel Hill, Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina, United States.
University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States.
University of North Carolina at Chapel Hill, Department of Epidemiology, Chapel Hill, North Carolina, United States.
University of North Carolina at Chapel Hill, UNC Center for Environmental Health and Susceptibility, Chapel Hill, North Carolina, United States.

Charles M Perou (CM)

University of North Carolina at Chapel Hill, Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina, United States.
University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States.
University of North Carolina at Chapel Hill, Department of Genetics, Chapel Hill, North Carolina, United States.

J S Marron (JS)

University of North Carolina at Chapel Hill, Department of Statistics and Operations Research, Chapel Hill, North Carolina, United States.
University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States.
University of North Carolina at Chapel Hill, Department of Biostatistics, Chapel Hill, North Carolina, United States.

Classifications MeSH